Profile picture for Paul Studenic, MD, PhD

Paul Studenic, MD, PhD

Paul Studenic is a clinical post-doc researcher at the Karolinska Institute in Stockholm. He did his PhD on clinical outcomes, patient perspective and methodological approaches in rheumatoid arthritis at the Medical University of Vienna in Austria and specialised in Internal medicine and Rheumatology. His main research interests are in outcome measurements in inflammatory arthritis and patient-reported outcomes. Follow him on Twitter: @Stiddyo

Articles By Paul Studenic, MD, PhD

pso.arm_.JPG

Which patients with psoriasis are at risk to develop PsA?

By Paul Studenic, MD, PhD

The potential transition from psoriasis (PsO) to psoriatic arthritis (PsA) has not been a strong focus for several years but is gaining momentum.

Read Article
depression oh no HA

Psoriatic arthritis mortality & morbidities

By Paul Studenic, MD, PhD

Psoriatic arthritis (PsA) is a chronic condition with manifold clinical presentations. Health issues may be far beyond the classical associated conditions like uveitis, enthesitis etc. The current study of Tillett et al (OP0231) assessed comorbidities and patient characteristics comparing psoriasis patients with or without PsA.

Read Article
×